PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
14-Jun-2022 PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300 PureTech
14-Jun-2022 Happify Health and Almirall Go Live with Digital Solution to Support Psoriasis Patients Almirall
14-Jun-2022 Sogroya® data show potential as once-weekly treatment in children living with growth hormone deficiency Novo Nordisk
14-Jun-2022 GENOMICS ENGLAND WILL ANCHOR CANARY WHARF LIFE SCIENCE CLUSTER GENOMICS ENGLAND
14-Jun-2022 Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including Omicron Sanofi
14-Jun-2022 Investigational phase 3 data for Sogroya® (somapacitan) injection in children with growth hormone deficiency presented today at the ENDO 2022 Congress1 Novo Nordisk
14-Jun-2022 Vertex to Present Data Demonstrating Benefits of Long-Term and Early Treatment With CFTR Modulators at the European Cystic Fibrosis Conference Vertex Pharmaceuticals
14-Jun-2022 Evotec enters a drug discovery collaboration with Janssen Evotec SE
13-Jun-2022 Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47 MorphoSys AG
13-Jun-2022 Gerresheimer AG: Gerresheimer partners with MedTech start-up Adamant Health to revolutionize treatment of Parkinson’s disease Gerresheimer AG
13-Jun-2022 Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil Relief Therapeutics Holding SA
10-Jun-2022 Abivax releases the results of its June 9, 2022 ordinary annual and extraordinary general meeting ABIVAX
10-Jun-2022 Weekly Life Science News Round Up: 6th – 10th June PharmiWeb.Jobs
10-Jun-2022 GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease Global Blood Therapeutics, Inc.
10-Jun-2022 Genmab Commences New Arbitration Under License Agreement With Janssen Genmab
10-Jun-2022 Tiziana Life Sciences PLC (TLSA: NASDAQ) Releases Research Report: Clinical Improvements for 2nd SPMS Patient Tiziana Life Sciences PLC
10-Jun-2022 Tiziana Life Sciences PLC (TLSA: NASDAQ) Clinical Improvements for 2nd SPMS Patient Tiziana Life Sciences PLC
10-Jun-2022 Blueprint Medicines Reports Continued Progress Toward Goal of Transforming Treatment of Systemic Mastocytosis Blueprint Medicines Corporation
10-Jun-2022 PEPperPRINT GmbH Introduces Novel Biomarker Set for Rheumatoid Arthritis Diagnosis at the 13th International Congress on Autoimmunity PEPperPRINT GmbH
10-Jun-2022 Santhera and ReveraGen to Present New Data with Vamorolone at 2022 Parent Project Muscular Dystrophy Conference Santhera and ReveraGen